Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Antidote Therapeutics, Inc

Clinical trials sponsored by Antidote Therapeutics, Inc, explained in plain language.

Trials to join now! 1

New antibody shot could trap nicotine in smokers

Symptom relief Recruiting now

This early-stage study tests a new drug called ATI-1013 in 15 healthy smokers. The drug is an antibody designed to bind to nicotine in the body. The main goal is to check safety and see how long the drug stays in the system. Participants get one IV dose of the drug or a placebo a…

Phase: PHASE1 • Sponsor: Antidote Therapeutics, Inc • Aim: Symptom relief

Last updated Jun 27, 2026 07:54 UTC